Application 071026

Type
ANDA
Sponsor
FRONTIDA BIOPHARM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXAZEPAMOXAZEPAMCAPSULE;ORAL30MGNoNo
002OXAZEPAMOXAZEPAMCAPSULE;ORAL10MGNoNo
003OXAZEPAMOXAZEPAMCAPSULE;ORAL15MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-290OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-291OxazepamOxazepamTruPharma, LLCANDACurrent
52817-292OxazepamOxazepamTruPharma, LLCANDACurrent
52817-292OxazepamOxazepamTruPharma, LLCANDACurrent
52817-292OxazepamOxazepamTruPharma, LLCANDACurrent
52817-292OxazepamOxazepamTruPharma, LLCANDACurrent
71610-639OxazepamOxazepamAphena Pharma Solutions - Tennessee, LLCANDACurrent